Baird lowered the firm’s price target on Iqvia to $235 from $240 and keeps an Outperform rating on the shares. The analyst said 1Q results largely in line with expectations, guidance unchanged, and universally positive RD&S demand commentary.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on IQV: